Frequent inactivation of the transforming growth factor β type ii receptor in small-cell lung carcinoma cells

Oncology Research

Volumn 9, Issue 2, 1997, Pages 89-98

  De Jonge, Rosalein R ^a   Garrigue Antar, Laure ^a   Vellucci, Vincent F ^a   Reiss, Michael ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

Receptor; Small cell lung carcinoma; Transforming growth factor

Indexed keywords

MESSENGER RNA; PRIMER DNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; DNA METHYLATION; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; LUNG TUMOR; METABOLISM; POLYMERASE CHAIN REACTION; PROMOTER REGION; SMALL CELL CARCINOMA;

CARCINOMA, SMALL CELL; DNA METHYLATION; DNA PRIMERS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030634624     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Cook, R. M.; Miller, Y. E.; Bunn, P. A., Jr. Small cell lung cancer: Etiology, biology, clinical features, staging, and treatment. Curr. Prob. Cancer 17:69-141; 1993.
2. Roberts, A. B.; Sporn, M. B. Physiological actions and clinical applications of transforming growth factor-beta (TGFbeta). Growth Factors 8:1-9; 1993.
3. Wakefield, L. M.; Letterio, J. J.; Geiser, A. G.; Flanders, K. C.; O'Shaughnessy, J.; Roberts, A. B.; Sporn, M. B. Transforming growth factor-betas in mammary tumorigenesis: Promoters or antipromoters? Prog. Clin. Biol. Res. 391:133-148; 1995.
4. Fynan, T. M.; Reiss, M. Resistance to inhibition of cell growth by transforming growth factor-/? and its role in oncogenesis. Crit. Rev. Oncog. 4:493-540; 1993.
5. Barcellos-Hoff, M. H. R.; Derynck, R.; Tsang, L.-S.; Weatherbee, J. A. Transforming growth factor-/3 activation in irradiated murine mammary gland. J. Clin. Invest. 93:892-899; 1994.
6. Bepler, G.; Rotsch, M.; Jaques, G.; Haeder, M.; Heymanns, J.; Hartogh, G.; Kiefer, P.; Havemann, K. Peptides and growth factors in small cell lung cancer: Production, binding sites, and growth effects. J. Cancer Res. Clin. Oncol. 114: 235-44; 1988.
7. Damstrup, L.; Rygaard, K.; Spang-Thomsen, M.; Skovgaard Poulsen, H. Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines. Br. J. Cancer 67:1015-21; 1993.
8. Fischer, J. R.; Darjes, H.; Lahm, H.; Schindel, M.; Drings, P.; Krammer, P. H. Constitutive secretion of bioactive transforming growth factor beta 1 by small cell lung cancer cell lines. Eur. J. Cancer 30A:2125-2129; 1994.
9. Jakowlew, S. B.; Mathias, A.; Chung, P.; Moody, T. W. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines. Cell Growth Differ. 6:465-476; 1995.
10. Norgaard, P.; Damstrup, L.; Rygaard, K.; Spang-Thomsen, M.; Skovgaard Poulsen, H. Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor. Br. J. Cancer 69:802-808; 1994.
11. Norgaard, P.; Spang-Thomsen, M.; Poulsen, H. S. Expression and autoregulation of transforming growth factor βreceptor mRNA in small-cell lung cancer cell lines. Br. J. Cancer 73:1037-1043; 1996.
12. Gazdar, A. F.; Carney, D. N.; Russell, E. K.; Sims, H. L.; Baylin, S. B.; Bunn, P. A., Jr.; Guccion, J. G.; Minna, J. D. Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res. 40:3502-3507; 1980.
13. Gazdar, A. F.; Carney, D. N.; Nau, M. M.; Minna, J. D. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res. 45:29242930; 1985.
14. Carney, D. N.; Gazdar, A. F.; Bepler, G.; Guccion, J. G.; Marangos, P. J.; Moody, T. W.; Zweig, M. H.; Minna, J. D. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 45:29132923; 1985.
15. Takahashi, T.; Nau, M. M.; Chiba, I.; Birrer, M. J.; Rosenberg, R. K.; Vinocour, M.; Levitt, M.; Pass, H.; Gazdar, A. F.; Minna, J. D. p53: A frequent target for genetic abnormalities in lung cancer. Science 246:491-494; 1989.
16. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159; 1987.
17. Lin, H. Y.; Wang, X.-F.; Ng-Eaton, E.; Weinberg, R. A.; Lodish, H. F. Expression cloning of the TGF-/3 type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785; 1992.
18. Takenoshita, S.; Hagiwara, K.; Nagashima, M.; Gemma, A.; Bennett, W. P.; Harris, C. C. The genomic structure of the gene encoding the human transforming growth factor βtype II receptor (TGF-/3 RII). Genomics 36:341-344; 1996.
19. Lu, S. L.; Zhang, W. C.; Akiyama, Y.; Nomizu, T.; Yuasa, Y. Genomic structure of the transforming growth factor β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res. 56:4595-4598; 1996.
20. Reiss, M.; Brash, D. E.; Munoz-Antonia, T.; Simon, J. A.; Ziegler, A.; Vellucci, V. F.; Zhou, Z.-L. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. Oncol. Res. 4:349-358; 1992.
21. Garrigue-Antar, L.; Munoz-Antonia, T.; Antonia, S. J.; Gesmonde, J.; Vellucci, V. F.; Reiss, M. Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Cancer Res. 55: 3982-3987; 1995.
22. Gonzalez-Zulueta, M.; Bender, C. M.; Yang, A. S.; Nguyen, T.; Beart, R. W.; Van Tornout, J. M.; Jones, P. A. Methylation of the 5 ' CpG island of the p!6/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55:4531-4535; 1995.
23. Humphries, D. E.; Bloom, B. B.; Fine, A.; Goldstein, R. H. Structure and expression of the promoter for the human type II transforming growth factor-beta receptor. Biochem. Biophys. Res. Commun. 203:1020-1027; 1994.
24. Bae, H. W.; Geiser, A. G.; Kirn, D. H.; Chung, M. T.; Burmester, J. K.; Sporn, M. B.; Roberts, A. B.; Kim, S.-J. Characterization of the promoter region of the human transforming growth factor-j3 type II receptor gene. J. Biol. Chem. 270: 29460-29468; 1995.
25. Gardiner-Garden, M.; Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol. 196:261-282; 1987.
26. Sun, L.; Wu, G.; Willson, J. K.; Zborowska, E.; Yang, J.; Rajkarunanayake, I.; Wang, J.; Gentry, L. E.; Wang, X.-F.; Brattain, M. G. Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem. 269:26449-26455; 1994.
27. Kalkhoven, E.; Roelen, B. A. J.; de Winter, J. P.; Mummery, C. L.; van den Eijnden-van Raaij, A. J. M.; van der Saag, P. T.; van der Burg, B. Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ. 6:1151-1156; 1995.
28. Munoz-Antonia, T.; Li, X.; Reiss, M.; Antonia, S. A mutation in the TGF-0 type II receptor gene promoter associated with loss of gene expression. Cancer Res. 56:4831-4835; 1996.
29. Herman, J. G.; Merlo, A.; Mao, L.; Lapidus, R. G.; Issa, J.-P. J.; Davidson, N. E.; Sidransky, D.; Baylin, S. B. Inactivation of the CDKN2/pl6/MTSI gene is frequently associ-
30. ated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:4525-4530; 1995.
31. Herman, J. G.; Latif, F.; Weng, Y.; Lerman, M. I.; Zbar, B.; Liu, S.; Samid, D.; Duan, D. S.; Gnarra, J. R.; Linehan, W. M.; Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91:9700-9704; 1994.
32. Garrigue-Antar, L.; Souza, R. F.; Vellucci, V. F.; Meltzer, S. J.; Reiss, M. Loss of transforming growth factor-/3 type II receptor gene expression in human esophageal cancer. Lab. Invest. 75:263-272; 1996.
33. Markowitz, S.; Wang, J.; Myeroff, L.; Parsons, R.; Sun, L.; Lutterbaugh, J.; Fan, R. S.; Zborowska, E.; Kinzler, K. W.; Vogelstein, B.; Brattain, M.; Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338; 1995.
34. Park, K.; Kirn, S.-J.; Bang, Y.-J.; Park, J.-G.; Kim, N. K.; Roberts, A. B.; Sporn, M. B. Genetic changes in the transforming growth factor β(TGF-/3) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to TGF-/3. Proc. Natl. Acad. Sci. USA 91:8772-8776; 1994.
35. Quandt, K.; Frech, K.; Karas, H.; Wingender, E.; Werner, T. Matlnd and Matlnspector -new fast and versatile tools for detection of consensus matches in nucleotide sequence databases. Nucleic Acid Res. 23:4878-4884; 1995.
36. Monte, D.; Baert, J. L.; Defossez, P. A.; de Launoit, Y.; Stehelin, D. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors. Oncogene 9: 1397-1406; 1994.
37. Golub, T. R.; Goga, A.; Barker, G. F.; Afar, D. E.; McLaughlin, J.; Bohlander, S. K.; Rowley, J. D.; Witte, O. N.; Gilliland, D. G. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol. 16: 4107-4116; 1996.
38. Buttice, G.; Kurkinen, M. A polyomavirus enhancer Abinding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene. J. Biol. Chem. 268:7196-7204; 1993.
39. Gum, R.; Lengyel, E.; Juarez, J.; Chen, J. H.; Sato, H.; Seiki, M.; Boyd, D. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor
40. binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271:10672-10680; 1996.
41. Bolon, I.; Gouyer, V.; Devouassoux, M.; Vandenbunder, B.; Wernert, N.; More, D.; Brambilla, C. ; Brambilla, E. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am. J. Pathol. 147:12981310; 1995.
42. Bolon, I.; Brambilla, E.; Vandenbunder, B.; Robert, C.; Lantuejoul, S.; Brambilla, C. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions. Lab. Invest. 75:113; 1996.
43. Zaidi, S. H.; Malter, J. S. Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3'untranslated region. J. Biol. Chem. 269:24007-24013; 1994.
44. Brand, T.; Schneider, M. D. Inactive type II and type I receptors for TGF-/3 are dominant inhibitors of TGF-/3-dependent transcription. J. Biol. Chem. 270:8274-8284; 1995.
45. Choi, M. E.; Ballerman, B. J. Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-/? receptors. J. Biol. Chem. 270: 21144-21150; 1995.
46. Yamamoto, H.; Ueno, H.; Ooshima, A.; Takeshita, A. Adenovirus-mediated transfer of a truncated transforming growth factor-/? (TGF-/3) type II receptor completely and specifically abolishes diverse signaling by TGF-/3 in vascular wall cells in primary culture. J. Biol. Chem. 271:16253-16259; 1996.
47. Zhao, Y.; Young, S. L. Requirement of transforming growth factor-/3 (TGF-/3) type II receptor for TGF-/3-induced proliferation and growth inhibition. J. Biol. Chem. 271:2369-2372; 1996.
48. Myeroff, L. L.; Parsons, R.; Kirn, S.-J.; Hedrick, L.; Cho, K. R.; Orth, K.; Mathis, M.; Kinzler, K. W.; Lutterbaugh, J.; Park, K.; Bang, Y.-J.; Lee, H. Y.; Park, J.-G.; Lynch, H. T.; Roberts, A. B.; Vogelstein, B.; Markowitz, S. D. A transforming growth factor βtype II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 55:5545-5547; 1995.
49. Parsons, R.; Myeroff, L. L.; Liu, B.; Willson, J. K. V.; Markowitz, S. D.; Kinzler, K. W.; Vogelstein, B. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res. 55: 5548-5550; 1995.